D&M Company Announces Investment Asset Balance (Consolidated) for May 2026

D&M Company Ltd. (Headquarters: Kita-ku, Osaka; Representative Director: Akiyoshi Matsushita; Securities Code: 189A) announces its investment asset balance on a monthly basis to enhance transparency and accelerate information disclosure to stakeholders. This key management metric reflects the company’s strategic focus on growth.

[Investment Asset Balance Trends for the May 2026 Period]

In May 2026, the number of companies from which receivables were purchased decreased by three compared to the previous month, totaling 99 at the end of May. This led to a reduction of JPY 172 million in purchased receivables. Combined with a decrease in operating loans, the total investment asset balance declined by JPY 183 million from the prior month, reaching JPY 9,521 million. However, over the full fiscal year ending May 2026, the number of receivables-purchasing clients increased by 21—from 78 at the end of May 2025 to 99 at the end of May 2026. Purchased receivables rose by JPY 1,305 million, from JPY 7,441 million to JPY 8,746 million. The total investment asset balance increased by JPY 1,200 million, from JPY 8,321 million to JPY 9,521 million.

[Why Investment Asset Balance Is a Key Metric]

The D&M Group provides integrated services to healthcare and nursing care providers, with a focus on operational support. Among these, the Finance & Investment (F&I) service serves as the foundation for other offerings. In the fiscal year ended May 2025, F&I accounted for 50.1% of consolidated sales with a gross profit margin of 68.9%, highlighting its critical role in overall business growth. The majority of F&I revenue comes from fees generated by purchasing medical and nursing care reimbursement receivables, with revenue calculated by applying a fixed rate to the purchased amount. Therefore, the company emphasizes the investment asset balance—including medical and nursing care receivables—as a key indicator of business expansion.

▶ D&M Company IR Information

https://www.dmcompany.co.jp/ir/

About D&M Company Ltd.

Under the philosophy of 'Development by Investment and Consulting'—aiming for revitalization, growth, and sustainable development—the company specializes in the healthcare, nursing care, and welfare services industries. It provides comprehensive, one-stop support in critical areas such as funding, management, and human resources. Rather than offering generic services, D&M designs and implements tailored solutions based on each client’s unique situation and needs. Leveraging the analytical and execution capabilities of finance and healthcare professionals, the company flexibly combines financial support, management consulting, and HR services. When internal expertise is insufficient, it utilizes its network to connect clients with optimal partners and talent. D&M’s vision is to realize patient-centered, high-quality, and sustainable healthcare. To ensure Japan’s healthcare, nursing care, and welfare systems remain world-class, the company supports the industry through both operational improvement and talent acquisition, striving to secure safety, peace of mind, and opportunities for all.